Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II)

Psychiatry Research - Neuroimaging

Volumn 140, Issue 3, 2005, Pages 301-307

  Papakostas, George I ^a   Iosifescu, Dan V ^a   Renshaw, Perry F ^b   Lyoo, In Kyoon ^b   Lee, Ho Kyu ^c   Alpert, Jonathan E ^a   Nierenberg, Andrew A ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c Sungkyunkwan University   (South Korea)

Author keywords

Cardiovascular; Depression; Folate; Hyperintensities; White matter

Indexed keywords

ANTIDEPRESSANT AGENT; CARBON; CHOLESTEROL; CYANOCOBALAMIN; FLUOXETINE; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CARBON CYCLE; CARBON METABOLISM; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; DRUG EFFECT; FAMILY HISTORY; FEMALE; FOLIC ACID BLOOD LEVEL; GERIATRIC PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; PRIORITY JOURNAL; RATING SCALE; REMISSION; SMOKING; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; BRAIN; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; VITAMIN B 12;

EID: 27844508065     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2005.09.001     Document Type: Article

References (29)

1. M. Alpert, R.R. Silva, and E.R. Pouget Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant Journal of Clinical Psychopharmacology 23 3 2003 309 313
2. A.L. Brody, S. Saxena, M.A. Mandelkern, L.A. Fairbanks, M.L. Ho, and L.R. Baxter Brain metabolic changes associated with symptom factor improvement in major depressive disorder Biological Psychiatry 50 3 2001 171 178
3. M. Fava, J.S. Borus, J.E. Alpert, A.A. Nierenberg, J.F. Rosenbaum, and T. Bottiglieri Folate, vitamin B12, and homocysteine in major depressive disorder American Journal of Psychiatry 154 3 1997 426 428
4. F. Fazekas, J.B. Chawluk, A. Alavi, H.I. Hurtig, and R.A. Zimmerman MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging American Journal of Roentgenology 149 2 1987 351 356
5. T. Fujikawa, N. Yokota, M. Muraoka, and S. Yamawaki Response of patients with major depression and silent cerebral infarction to antidepressant drug therapy, with emphasis on central nervous system adverse reactions Stroke 27 11 1996 2040 2042
6. A. Graff-Guerrero, J. Gonzalez-Olvera, Y. Mendoza-Espinosa, V. Vaugier, and J.C. Garcia-Reyna Correlation between cerebral blood flow and items of the Hamilton Rating Scale for Depression in antidepressant-naive patients Journal of Affective Disorders 80 1 2004 55 63
7. M. Hamilton Development of a rating scale for primary depressive illness British Journal of Social and Clinical Psychology 6 1967 278 296
8. I. Hickie, E. Scott, K. Wilhelm, and H. Brodaty Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression-a longitudinal evaluation Biological Psychiatry 42 5 1997 367 374
9. D.V. Iosifescu, N. Clementi-Craven, R. Fraguas, G.I. Papakostas, T. Petersen, J.E. Alpert, A.A. Nierenberg, and M. Fava Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder Psychosomatic Medicine 67 2005 703 706
10. D.V. Iosifescu, G.I. Papakostas, I.K. Lyoo, H.K. Lee, P.F. Renshaw, J.E. Alpert, and M. Fava Brain MRI white matter hyperintensities, cardiovascular risk factors and one-carbon cycle metabolism in non-geriatric outpatients with major depression (Part 1) Psychiatry Research Neuroimaging 140 2005 291 299
11. Iosifescu, D.V., Renshaw, P.F., Lyoo, I.K., Lee, H.K., Perlis, R.H., Papakostas, G.I., Nierenberg, A.A., Fava, M., in press. Brain MRI white matter hyperintensities, cardiovascular risk factors, and treatment outcome in major depressive disorder. British Journal of Psychiatry.
12. J.M. Lyness, D.A. King, Y. Conwell, C. Cox, and E.D. Caine Cerebrovascular risk factors and 1-year depression outcome in older primary care patients American Journal of Psychiatry 157 9 2000 1499 1501
13. M.P. Mattson, and T.B. Shea Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders Trends in Neurosciences 26 3 2003 137 146
14. National Institutes of Health Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III) 2001 NIH Bethesda, MD
15. J. O'Brien, D. Ames, E. Chiu, I. Schweitzer, P. Desmond, and B. Tress Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study British Medical Journal 317 1998 982 984
16. G.I. Papakostas, T. Petersen, S. Sonawalla, W. Merens, J.E. Alpert, D.V. Iosifescu, and M. Fava Serum cholesterol in treatment-resistant depression Neuropsychobiology 47 3 2003 146 151
17. G.I. Papakostas, J.E. Alpert, and M. Fava SAME in the treatment of depression: a comprehensive review of the literature Current Psychiatry Reports 5 6 2003 460 466
18. G.I. Papakostas, D.V. Iosifescu, T. Petersen, S.K. Hamill, J.E. Alpert, A.A. Nierenberg, J.F. Rosenbaum, and M. Fava Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorder Journal of Clinical Psychopharmacology 24 4 2004 467 469
19. G.I. Papakostas, T. Petersen, D. Mischoulon, J.L. Ryan, A.A. Nierenberg, T. Bottiglieri, and M. Fava Serum folate, vitamin B12 and homocysteine in major depressive disorder part 1: predictors of clinical response in fluoxetine-resistant depression Journal of Clinical Psychiatry 65 8 2004 1090 1095
20. G.I. Papakostas, T. Petersen, D. Mischoulon, C.H. Green, A.A. Nierenberg, T. Bottiglieri, and M. Fava Serum folate, vitamin B12 and homocysteine in major depressive disorder part 2: predictors of relapse during the continuation phase of pharmacotherapy Journal of Clinical Psychiatry 65 8 2004 1096 1098
21. G.I. Papakostas, T. Petersen, B.D. Lebowitz, D. Mischoulon, J.L. Ryan, A.A. Nierenberg, T. Bottiglieri, J.E. Alpert, J.F. Rosenbaum, and M. Fava The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine International Journal of Neuropsychopharmacology 8 4 2005 523 528
22. S. Simpson, R.C. Baldwin, A. Jackson, and A.S. Burns Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression Psychological Medicine 28 5 1998 1015 1026
23. S.B. Sonawalla, G.I. Papakostas, T.J. Petersen, A.S. Yeung, M.M. Smith, A.H. Sickinger, and M. Fava Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder Psychosomatics 43 4 2002 310 316
24. G. Spalletta, G. Guida, and C. Caltagirone Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance? Journal of Neurology 250 4 2003 449 455 (Apr)
25. R.L. Spitzer, J.B.W. Williams, M. Gibbon, and M. First Structured Clinical Interview for DSM-III-R Patient Edition (SCID-P) 1989 New York State Psychiatric Institute, Biometrics Research Department New York
26. D.C. Steffens, K.R. Krishnan, C. Crump, and G.L. Burke Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study Stroke 33 6 2002 1636 1644
27. W.D. Taylor, J.R. MacFall, J.M. Provenzale, M.E. Payne, D.R. McQuoid, D.C. Steffens, and K.R. Krishnan Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors American Journal of Roentgenology 181 2 2003 571 576
28. J.B. Ubbink, W.J.H. Vermark, and S. Bissbort Rapid high-performance liquid chromatography assay for total homocysteine levels in human serum Journal of Chromatography 565 1991 441 446
29. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 18 1998 1837 1847